Back
California Resources Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
38
CRC
California Resources
Last Price:
51.24
Seasonality Move:
17.69%
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
32.97
Seasonality Move:
6.63%
Sell
38
California Resources (CRC)
is a Sell
Is California Resources a Buy, Sell or Hold?
- The current California Resources [CRC] share price is $51.49. The Score for CRC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CRC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $33.15. The Score for MIRM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRC Stock Price Chart
What is California Resources's stock price today?
-
The California Resources share price today is $51.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRC is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $33.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.
CRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 60.06 | Buy |
| Chaikin Money Flow: | 385341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46 - 49.72) | Buy |
| Bollinger Bands (100): | (48.42 - 54.92) | Sell |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.01 | Buy |
| Relative Strength Index (14 RSI): | 64.44 | Buy |
| Chaikin Money Flow: | -648557 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.98 - 30.18) | Buy |
| Bollinger Bands (100): | (24.4 - 28.72) | Buy |
CRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.89 | Buy |
| 20-day SMA: | 47.92 | Buy |
| 50-day SMA: | 50.1 | Buy |
| 200-day SMA: | 52.31 | Sell |
| 8-day EMA: | 49.89 | Buy |
| 20-day EMA: | 48.97 | Buy |
| 50-day EMA: | 49.76 | Buy |
| 200-day EMA: | 50.73 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.76 | Buy |
| 20-day SMA: | 27.49 | Buy |
| 50-day SMA: | 25.93 | Buy |
| 200-day SMA: | 28.17 | Buy |
| 8-day EMA: | 31.17 | Buy |
| 20-day EMA: | 28.66 | Buy |
| 50-day EMA: | 27.01 | Buy |
| 200-day EMA: | 27 | Buy |
California Resources Earnings Growth & CRC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.09 per share, a decrease next quarter of $0.46 per share, a decrease this year of $0.00 per share, and an increase next year of $1.02 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
California Resources Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||